Home › Funds › GENERAL ATLANTIC, L.P. › SPTX
GENERAL ATLANTIC, L.P. position in SPTX
SEAPORT THERAPEUTICS INC · Health Care
GENERAL ATLANTIC, L.P. reported holding 6,101,582 shares of SPTX (SEAPORT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$123.1M, representing 5.05% of its reported portfolio and ranking #6 among its reported holdings. GENERAL ATLANTIC, L.P. has disclosed SPTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How GENERAL ATLANTIC, L.P.'s SPTX position evolved
GENERAL ATLANTIC, L.P. first disclosed a stake in SPTX in Q2 2026 at 6,101,582 shares (US$132.5M). Across 2 filings, GENERAL ATLANTIC, L.P. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 6,101,582 shares valued at US$123.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 6.10M | $132.53M | New |
| Q3 2026 | 6.10M | $123.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SPTX and 13F data
SPTX (SEAPORT THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in SPTX — the largest reported positions include ARCH Venture Management, LLC (US$136.6M), Sofinnova Investments, Inc. (US$77.4M), TRV GP VI, LLC (US$44.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SPTX
- ARCH Venture Management, LLC 6.29M sh · $136.60M · Q2 2026
- Sofinnova Investments, Inc. 3.56M sh · $77.43M · Q2 2026
- TRV GP VI, LLC 2.06M sh · $44.77M · Q2 2026
- Foresite Capital Management VI LLC 1.78M sh · $38.65M · Q2 2026
- Bellevue Group AG 1.10M sh · $23.89M · Q2 2026
- Siren, L.L.C. 1.10M sh · $22.09M · Q3 2026
More on GENERAL ATLANTIC, L.P.
FAQ
How long has GENERAL ATLANTIC, L.P. held SPTX?
GENERAL ATLANTIC, L.P. has disclosed SPTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is GENERAL ATLANTIC, L.P.'s current position in SPTX?
As of Q3 2026, GENERAL ATLANTIC, L.P. holds 6.10M shares of SPTX (SEAPORT THERAPEUTICS INC), valued at $123.07M, representing 5.05% of its reported portfolio and ranking #6.
Has GENERAL ATLANTIC, L.P. been buying or selling SPTX?
In the latest 13F filing (Q3 2026), GENERAL ATLANTIC, L.P. held unchanged its position in SPTX.
Which other funds hold SPTX?
Other major institutional holders of SPTX include ARCH Venture Management, LLC, Sofinnova Investments, Inc., TRV GP VI, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.